comparemela.com

Latest Breaking News On - Scientific company profile - Page 2 : comparemela.com

Core Scientific (NASDAQ:CORZ) Stock Rating Lowered by Zacks Investment Research

Core Scientific (NASDAQ:CORZ – Get Rating) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Core Scientific Holding Co. provides customizable infrastructure and software solutions to customers for blockchain hosting and digital asset mining. […]

Danimer Scientific, Inc (NYSE:DNMR) Expected to Post Q3 2022 Earnings of ($0 20) Per Share

Danimer Scientific, Inc. (NYSE:DNMR – Get Rating) – Analysts at Jefferies Financial Group issued their Q3 2022 earnings per share (EPS) estimates for Danimer Scientific in a report issued on Monday, May 23rd. Jefferies Financial Group analyst L. Alexander anticipates that the company will post earnings of ($0.20) per share for the quarter. Jefferies Financial […]

Financial Analysis: Coloplast A/S (OTCMKTS:CLPBY) & Milestone Scientific (NYSE:MLSS)

Coloplast A/S (OTCMKTS:CLPBY – Get Rating) and Milestone Scientific (NYSE:MLSS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a breakdown of current ratings and […]

Core Scientific (NASDAQ:CORZ) Raised to Strong-Buy at Zacks Investment Research

Core Scientific (NASDAQ:CORZ – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a report issued on Thursday, Zacks.com reports. The firm presently has a $4.25 price objective on the stock. According to Zacks, “Core Scientific Holding Co. provides customizable infrastructure and software solutions to customers for […]

Analysts Expect Boston Scientific Co (NYSE:BSX) Will Announce Quarterly Sales of $3 22 Billion

Analysts expect Boston Scientific Co. (NYSE:BSX – Get Rating) to post sales of $3.22 billion for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have provided estimates for Boston Scientific’s earnings, with the lowest sales estimate coming in at $3.20 billion and the highest estimate coming in at $3.24 billion. Boston Scientific […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.